Traws Pharma, Inc.TRAWNASDAQ

52-Week Range1-19

0.97Current 2.3519.44

Want to monitor TRAW?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

onconova therapeutics, inc.

Professional, Scientific, and Technical Services

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Steven Fruchtman

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

APO Investors Have Opportunity to Lead Apollo Global Management, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Nvidia's Huang pitches AI tokens on top of salary as agents reshape how humans work

Inside Alibaba's reset: 34% job cuts, profit shock, and AI gamble

Smiths Group to Return Extra $2 Billion to Shareholders

Wetherspoon warns profits may fall short as costs bite

Tesla taps China for $2.9B solar gear in major US expansion push: report

Unilever confirms talks with McCormick over sale of foods business

Natural Gas and Oil Forecast: Strait Risks Keep Oil Near $94 – $100 Next?

Kolibri Global Energy Inc. (KEI:CA) Q4 2025 Earnings Call Transcript

Can SoFi Stock Reach $30 by the End of 2026?

Navan, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NAVN

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript

Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT

Alstom S.A : Alstom signs a 5-year contract extension to operate and maintain the GO Transit and UP express fleets in Toronto, Canada

Tesla's New Robotic Rival Has a Strangely Familiar Face

Enphase Energy, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ENPH

Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader

India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry

uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

About